Background Seasonal influenza is responsible for a large disease and economic burden.
Despite the expanding recommendation of influenza vaccination, influenza has continued to …

Influenza viruses cause significant morbidity and mortality in older adults. Prevention and
treatment are critical for the reduction of morbidity and mortality in this population, but there …

Background Empiric antibiotic treatment is common among children with acute respiratory
tract infections (ARTI), despite infections being predominately viral. The use of molecular …

We investigated the predictors of neuraminidase inhibitor (NAI) treatment in severe
hospitalised influenza cases and the association between antiviral treatment and mortality …

Objectives Little is known about the economic burden of influenza‐related hospitalizations in
Japan. This study sought to identify the factors that contribute to the total healthcare costs …

Thailand has a high incidence and high mortality rates of influenza. This study summarizes
the evidence on economic burden or costs of influenza subsequent to the occurrence of …

OBJECTIVES: To determine whether baloxavir use is associated with lower health care
resource utilization (HCRU) and costs for secondary influenza complications post treatment …

Background Respiratory complications often accompany influenza in patients with chronic
obstructive pulmonary disease (COPD). In this retrospective study, we quantified the impact …

The outbreak of seasonal flu costs billions of dollars in health care utilization and lost
productivity. Despite the effectiveness of vaccination and antiviral medications to prevent …

Aims To determine the effect of antiviral agents on influenza-related complications, health
care resource utilization (HRU), and costs over three influenza seasons (2014–2016) …